150 related articles for article (PubMed ID: 15283323)
21. [Is the index of response to erythropoietin (IRE) a good marker of adequate dialysis?].
Pérez-García R; Rodríguez-Benítez P; Villaverde MT; Valderrábano F
Nefrologia; 2001; 21(6):606-7. PubMed ID: 11881433
[No Abstract] [Full Text] [Related]
22. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome.
Sinico RA; Di Toma L; Maggiore U; Bottero P; Radice A; Tosoni C; Grasselli C; Pavone L; Gregorini G; Monti S; Frassi M; Vecchio F; Corace C; Venegoni E; Buzio C
Arthritis Rheum; 2005 Sep; 52(9):2926-35. PubMed ID: 16142760
[TBL] [Abstract][Full Text] [Related]
23. Diffuse alveolar hemorrhage in limited cutaneous systemic sclerosis with positive perinuclear antineutrophil cytoplasmic antibodies.
Vázquez-Del Mercado M; Mendoza-Topete A; Best-Aguilera CR; Garcia-De La Torre I
J Rheumatol; 1996 Oct; 23(10):1821-3. PubMed ID: 8895168
[TBL] [Abstract][Full Text] [Related]
24. Extracorporeal membrane oxygenation for the management of respiratory failure caused by diffuse alveolar hemorrhage.
Guo Z; Li X; Jiang LY; Xu LF
J Extra Corpor Technol; 2009 Mar; 41(1):37-40. PubMed ID: 19361031
[TBL] [Abstract][Full Text] [Related]
25. Hepcidin serum levels and resistance to recombinant human erythropoietin therapy in haemodialysis patients.
Costa E; Swinkels DW; Laarakkers CM; Rocha-Pereira P; Rocha S; Reis F; Teixeira F; Miranda V; do Sameiro Faria M; Loureiro A; Quintanilha A; Belo L; Santos-Silva A
Acta Haematol; 2009; 122(4):226-9. PubMed ID: 19887781
[No Abstract] [Full Text] [Related]
26. Management of anemia of chronic renal failure.
Singh NP; Anuradha S; Chandrashekhar ; Agarwal SK
J Assoc Physicians India; 1999 Feb; 47(2):216-23. PubMed ID: 10999096
[No Abstract] [Full Text] [Related]
27. Erythrocytosis in a patient on hemodialysis for thirteen years.
Kaynar K; Dilli UD; Akdogan R; Akdogan E; Ozdemir F; Cobanoglu U; Gul S; Ulusoy S
Mt Sinai J Med; 2006 Dec; 73(8):1095-7. PubMed ID: 17285202
[TBL] [Abstract][Full Text] [Related]
28. [Bronchectasia and microscopic polyangeitis].
Koninck JC; Diot E; Hazouard E; Machet MC; Valentin JF; Lemarie E; Diot P
Rev Pneumol Clin; 2002 Nov; 58(5 Pt 1):290-5. PubMed ID: 12486380
[TBL] [Abstract][Full Text] [Related]
29. Severe pulmonary hemorrhage in patients with end-stage renal disease in antineutrophil cytoplasmic autoantibody-associated vasculitis.
Chen M; Zhao MH
Am J Med Sci; 2009 Jun; 337(6):411-4. PubMed ID: 19359982
[TBL] [Abstract][Full Text] [Related]
30. Role of C-reactive protein, reticulocyte haemoglobin content and inflammatory markers in iron and erythropoietin administration in dialysis patients.
El-Khatib M; Duncan HJ; Kant KS
Nephrology (Carlton); 2006 Oct; 11(5):400-4. PubMed ID: 17014552
[TBL] [Abstract][Full Text] [Related]
31. Immunosuppressive therapy and clinical evolution in forty-nine patients with antineutrophil cytoplasmic antibody-associated glomerulonephritis.
Kokolina E; Alexopoulos E; Dimitriadis C; Vainas A; Giamalis P; Papagianni A; Ekonomidou D; Memmos D
Ann N Y Acad Sci; 2005 Jun; 1051():597-605. PubMed ID: 16127000
[TBL] [Abstract][Full Text] [Related]
32. [Problems in the treatment of the anemic syndrome in patients with chronic kidney failure].
Dvoretskiĭ LI; Vorob'ev PA; Iaroslavtseva GN; Granich LP; Zaĭtsev SV
Ter Arkh; 1986; 58(8):77-81. PubMed ID: 3764767
[TBL] [Abstract][Full Text] [Related]
33. The effect of high-flux hemodialysis on renal anemia.
Ayli D; Ayli M; Azak A; Yüksel C; Kosmaz GP; Atilgan G; Dede F; Abayli E; Camlibel M
J Nephrol; 2004; 17(5):701-6. PubMed ID: 15593038
[TBL] [Abstract][Full Text] [Related]
34. The role of erythropoietin in the anemia of chronic renal failure.
Krane NK
Henry Ford Hosp Med J; 1983; 31(3):177-81. PubMed ID: 6358139
[No Abstract] [Full Text] [Related]
35. Do hemodialysis patients need higher doses of erythropoietin if given intravenously rather than subcutaneously?
McMahon LP
Nat Clin Pract Nephrol; 2006 May; 2(5):246-7. PubMed ID: 16932434
[No Abstract] [Full Text] [Related]
36. Erythropoietin resistance in the treatment of the anemia of chronic renal failure.
Priyadarshi A; Shapiro JI
Semin Dial; 2006; 19(4):273-8. PubMed ID: 16893403
[TBL] [Abstract][Full Text] [Related]
37. Factors affecting anemia management in hemodialysis patients: a single-center experience.
Spiegel DM; Gitlin M; Mayne T
Hemodial Int; 2008 Jul; 12(3):336-41. PubMed ID: 18638090
[TBL] [Abstract][Full Text] [Related]
38. Responsiveness to erythropoietin and intrinsic inflammatory status in haemodialysis.
Romero R; Novoa D; Perez-Freiria A; Alonso R; Donapetry C; Sanchez-Guisande D
Nephrol Dial Transplant; 1994; 9(11):1696-7. PubMed ID: 7870370
[No Abstract] [Full Text] [Related]
39. Effect of epoetin zeta for correction of renal anemia in hemodialysis patients with thalassemia minor.
Kumchev E; Koytchev R; Dimitrakov D; Stavrev P; Tsochev G; Siebert-Weigel M
Adv Ther; 2008 Dec; 25(12):1375-8. PubMed ID: 19043680
[TBL] [Abstract][Full Text] [Related]
40. [Alveolar hemorrhage].
García-Casasola G; Alvarez-Sala JL; Martínez R; Cabello J; Espinós D
Rev Clin Esp; 1990 Nov; 187(8):412-7. PubMed ID: 2091136
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
